• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Fitbit Enters Substance Abuse Recovery with Pretaa Partnership

Share:

October 18, 2022

What You Should Know:

– Fitbit announced that they are partnering with behavioral analytics company Pretaa to improve outcomes for the millions of Americans affected by substance abuse. Pretaa analyzes information from wearable devices worn by those recovering from substance abuse and (with patient consent) notifies their care providers, friends and family members when they might need additional support.

– Research indicates that the onset of the pandemic was associated with an increase in overdose deaths nationally, driven by a number of factors including less access to interventions and increased stress due to isolation.

– As part of the partnership, Pretaa will incorporate Fitbit data into their analytics platform to help providers have a more holistic view of their patients. The goal is to help providers and caregivers deliver more personalized care via actionable information.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Hitconsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • GB Sciences Announces the Sale of the Majority Interest in Nevada Cultivation Operations to Focus on its First Two Cannabinoid-Based Medical Compounds for Parkinson’s Disease and Neuropathic PainGB Sciences Announces the Sale of the Majority Interest in Nevada Cultivation Operations to Focus on its First Two Cannabinoid-Based Medical Compounds for Parkinson’s Disease and Neuropathic Pain
  • Va Sees a Surge in Veterans’ Use of Telehealth ServicesVa Sees a Surge in Veterans’ Use of Telehealth Services
  • Eye Health America Announces Newest Acquisition of Eye Centers of Florida
  • Thermo Fisher Scientific Completes Sale of Anatomical Pathology Business to PHC Holdings CorporationThermo Fisher Scientific Completes Sale of Anatomical Pathology Business to PHC Holdings Corporation
  • A Year After Parntering with iota, Astellas Snaps Up the CompanyA Year After Parntering with iota, Astellas Snaps Up the Company
  • Pear’s reSET-O for Opioid Use Disorder Saves Payers $2,150 Per Patient, Real-world Claims Review FindsPear’s reSET-O for Opioid Use Disorder Saves Payers $2,150 Per Patient, Real-world Claims Review Finds
  • Butterfly Rescinds Features from Handheld Ultrasound Device, Working with FDA to Re-EnableButterfly Rescinds Features from Handheld Ultrasound Device, Working with FDA to Re-Enable
  • Mercy Virtual Leads $10M Investment in Myia Labs, Rolls out Home Monitoring tech to PatientsMercy Virtual Leads $10M Investment in Myia Labs, Rolls out Home Monitoring tech to Patients

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications